BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $6,000 | -14.3% | 70 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | -96.7% | 70 | -96.2% | 0.00% | -100.0% |
Q4 2020 | $209,000 | +21.5% | 1,860 | 0.0% | 0.01% | +33.3% |
Q3 2020 | $172,000 | +18.6% | 1,860 | 0.0% | 0.01% | +12.5% |
Q2 2020 | $145,000 | +30.6% | 1,860 | -1.6% | 0.01% | +33.3% |
Q1 2020 | $111,000 | -26.5% | 1,890 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $151,000 | +8.6% | 1,890 | 0.0% | 0.01% | +20.0% |
Q3 2019 | $139,000 | +17.8% | 1,890 | +51.2% | 0.01% | +25.0% |
Q2 2019 | $118,000 | +18.0% | 1,250 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $100,000 | -60.2% | 1,250 | -73.1% | 0.00% | -66.7% |
Q4 2018 | $251,000 | -32.3% | 4,650 | -2.1% | 0.01% | -18.2% |
Q3 2018 | $371,000 | +25.8% | 4,750 | +2.2% | 0.01% | +22.2% |
Q2 2018 | $295,000 | -29.3% | 4,650 | +2.2% | 0.01% | -35.7% |
Q1 2018 | $417,000 | -33.0% | 4,550 | -44.8% | 0.01% | -30.0% |
Q4 2017 | $622,000 | +8.2% | 8,250 | 0.0% | 0.02% | +5.3% |
Q3 2017 | $575,000 | – | 8,250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |